0001250853-22-000063.txt : 20220519 0001250853-22-000063.hdr.sgml : 20220519 20220519205132 ACCESSION NUMBER: 0001250853-22-000063 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200607 FILED AS OF DATE: 20220519 DATE AS OF CHANGE: 20220519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verleun Noah CENTRAL INDEX KEY: 0001862713 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-12627 FILM NUMBER: 22945033 MAIL ADDRESS: STREET 1: 2709 SKYPARK DRIVE STREET 2: SUITE 105 CITY: TORRANCE STATE: CA ZIP: 90505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Clean Energy Holdings, Inc. CENTRAL INDEX KEY: 0000748790 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 870407858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2790 SKYPARK DRIVE, SUITE 105 CITY: TORRANCE STATE: CA ZIP: 90505 BUSINESS PHONE: (310) 641-4234 MAIL ADDRESS: STREET 1: 2790 SKYPARK DRIVE, SUITE 105 CITY: TORRANCE STATE: CA ZIP: 90505 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL DISCOVERIES INC DATE OF NAME CHANGE: 19940303 FORMER COMPANY: FORMER CONFORMED NAME: WPI PHARMACEUTICAL INC DATE OF NAME CHANGE: 19930126 FORMER COMPANY: FORMER CONFORMED NAME: WESTPORT PHARMACEUTICAL INC DATE OF NAME CHANGE: 19850111 3/A 1 primary_doc.xml PRIMARY DOCUMENT X0206 3/A 2020-06-07 2021-06-22 0 0000748790 Global Clean Energy Holdings, Inc. GCEH 0001862713 Verleun Noah 2790 SKYPARK DRIVE SUITE 105 TORRANCE CA 90505 0 1 0 0 EVP - Development & Regulatory Stock Option (right to buy) 0.0035 2023-09-16 Common Stock 2757143 D The stock option was 25% vested on the grant date (09/17/2018). The remaining 75% vested in 36 equal installments beginning on the grant date. The original Form 3 underreported the number of shares by 500,000 shares. The original Form 3 reported 2,257,143 shares; it should have reported 2,757,143 shares. The Issuer effected a 1-for-10 reverse stock split on March 26, 2021, which subsequently reduced the number of options to 275,714 and increased the conversion price to $0.035. On the date that the original Form 3 was filed, 06/22/2021, the title of the reporting person was EVP - Development & Regulatory Affairs. On the date that this amendment is being filed, 05/19/2022, the title of the reporting person is President. /s/ Noah Verleun 2022-05-19